// App-Quantinova.ai

: Factors associated with exacerbations in patients with COPD: NOVELTY study

Researchers

Presenter

  • Hana Müllerová

Principal Investigators

  • Bo Ding

  • Eleni Rapsomaniki

  • Richard Beasley

  • J Mark Fitzgerald

  • Tim Harrison

  • Rod Hughes

  • Jose Maria Olaguibel

  • Helen K Reddel

  • Precil Varghese

  • Mohsen Sadatsafavi

  • Christer Janson

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand

  • Centre for Heart and Lung Health, The Lung Centre Vancouver General Hospital, UBC Institute for Heart and Lung Health, Vancouver, BC, Canada,

  • Faculty of Medicine and Health Sciences, Nottingham City Hospital, Nottingham, United Kingdom

  • Severe Asthma Unit, Complejo Hospitalario de Navarra, CIBERES, Pamplona, Spain

  • Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

  • AstraZeneca, Gaithersberg, MD, United States,

  • Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Locations

  • United Kingdom

  • Sweden

  • New Zealand

  • Canada

  • Spain

  • Australia

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • NCT02760329

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved